Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study

Phase Ii Study ◽

Neurofibromatosis Type ◽

Abstract CT233: Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trial

10.1158/1538-7445.am2019-ct233 ◽

2019 ◽

Author(s):

Chie-Schin Shih ◽

Jaishri Blakeley ◽

D. Wade Clapp ◽

Amy E. Armstrong ◽

Pam Wolters ◽

...

Keyword(s):

Clinical Trials ◽

Phase Ii ◽

Phase Ii Trial ◽

Neurofibromatosis Type ◽

Abstract CT233: Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trial

10.1158/1538-7445.sabcs18-ct233 ◽

2019 ◽

Author(s):

Chie-Schin Shih ◽

Jaishri Blakeley ◽

D. Wade Clapp ◽

Amy E. Armstrong ◽

Pam Wolters ◽

...

Keyword(s):

Clinical Trials ◽

Phase Ii ◽

Phase Ii Trial ◽

Neurofibromatosis Type ◽

SPRINT: Phase II study of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).

10.1200/jco.2018.36.15_suppl.10503 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 10503-10503 ◽

Cited By ~ 11

Author(s):

Andrea M. Gross ◽

Pamela Wolters ◽

Andrea Baldwin ◽

Eva Dombi ◽

Michael J. Fisher ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Neurofibromatosis Type ◽

NFM-07. SPRINT: PHASE II STUDY OF THE MEK 1/2 INHIBITOR SELUMETINIB (AZD6244, ARRY-142886) IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND INOPERABLE PLEXIFORM NEUROFIBROMAS (PN)

Neuro-Oncology ◽

10.1093/neuonc/noy059.515 ◽

2018 ◽

Vol 20 (suppl_2) ◽

pp. i143-i144 ◽

Cited By ~ 2

Author(s):

Andrea Gross ◽

Pamela Wolters ◽

Andrea Baldwin ◽

Eva Dombi ◽

Michael J Fisher ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Neurofibromatosis Type ◽

Phase II Study of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).

10.1200/jco.2016.34.15_suppl.tps10586 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS10586-TPS10586

Author(s):

Andrea M Gross ◽

Andrea Baldwin ◽

Eva Dombi ◽

Pamela Wolters ◽

Patricia Whitcomb ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Neurofibromatosis Type ◽

Abstract PR07: Phase II Trial of the MEK 1/2 inhibitor selumetinib (AZD6344, ARRY-142886 hydrogen sulphate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN)

10.1158/1535-7163.targ-19-pr07 ◽

2019 ◽

Cited By ~ 1

Author(s):

Geraldine O'Sullivan Coyne ◽

Andrea Gross ◽

Eva Dombi ◽

Jennifer DeSanto ◽

Amanda Carbonell ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Neurofibromatosis Type ◽

Plexiform Neurofibromas ◽

Hydrogen Sulphate

Phase II trial of the MEK1/2 inhibitor selumetinib (AZD6244) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs).

10.1200/jco.2016.34.15_suppl.tps2596 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS2596-TPS2596 ◽

Cited By ~ 1

Author(s):

Diana Bradford ◽

Patricia Whitcomb ◽

Eva Dombi ◽

Alice P. Chen ◽

Andrea Baldwin ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Neurofibromatosis Type ◽

NFM-01. NF105: A PHASE II PROSPECTIVE STUDY OF CABOZANTINIB (XL184) FOR PLEXIFORM NEUROFIBROMAS IN SUBJECTS WITH NEUROFIBROMATOSIS TYPE 1: A NEUROFIBROMATOSIS CLINICAL TRIAL CONSORTIUM (NFCTC) STUDY

Neuro-Oncology ◽

10.1093/neuonc/noy059.510 ◽

2018 ◽

Vol 20 (suppl_2) ◽

pp. i142-i142

Author(s):

Chie-Schin Shih ◽

Jaishri Blakely ◽

Wade Clapp ◽

Pam Wolters ◽

Eva Dombi ◽

...

Keyword(s):

Clinical Trial ◽

Prospective Study ◽

Phase Ii ◽

Neurofibromatosis Type ◽

SARC016: Phase II study of everolimus in combination with bevacizumab in sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors (MPNST).

10.1200/jco.2016.34.15_suppl.11053 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 11053-11053 ◽

Cited By ~ 12

Author(s):

Brigitte C. Widemann ◽

Christian Frederick Meyer ◽

Gregory Michael Cote ◽

Rashmi Chugh ◽

Mohammed M. Milhem ◽

...

Keyword(s):

Peripheral Nerve ◽

Phase Ii ◽

Phase Ii Study ◽

Neurofibromatosis Type ◽

Nerve Sheath Tumors ◽

Peripheral Nerve Sheath Tumors ◽

Nerve Sheath

Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas

Pediatric Blood & Cancer ◽

10.1002/pbc.25041 ◽

2014 ◽

Vol 61 (9) ◽

pp. 1598-1602 ◽

Cited By ~ 37

Author(s):

Brigitte C. Widemann ◽

Dusica Babovic-Vuksanovic ◽

Eva Dombi ◽

Pamela L. Wolters ◽

Stewart Goldman ◽

...

Keyword(s):

Young Adults ◽

Phase Ii ◽

Phase Ii Trial ◽

Neurofibromatosis Type ◽

Plexiform Neurofibromas ◽

Children And Young Adults